Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...

Gilead Sciences (NASDAQ:GILD) and Danish pharmaceutical company LEO Pharma on Saturday announced an agreement worth up to ...

Gilead Sciences, Inc. (Nasdaq: GILD) and LEO Pharma today announced a strategic partnership to accelerate the development and commercialization of LEO ...

Gilead Sciences, Inc. (GILD) and LEO Pharma entered strategic partnership to develop and commercialize LEO Pharma's small molecule ...

Gilead continues its divergence out of its original infectious disease beginnings and into cancer and now, more deeply than ...

Docking Drawer's Unwavering Dedication to Safety "At Docking Drawer, we're not just creating products; we're setting new standards for safety and functionality."When it comes to safety, no one in the ...

Between December 30, 2024, and January 3, 2025, Essity Aktiebolag (publ) repurchased a total of 162,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved ...

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Stocks like Tata Steel, Dr Reddy’s Laboratories, WPIL, Rail Vikas Nigam, Mahindra and Mahindra, Mankind Pharma, CESC, ...

Former Head of Global R&D at Bayer AG and an exceptional leader with a wealth of experience across biopharma Pivotal time of transition as the company ...

Leo, Daily Horoscope Today, January 8, 2025: Keep your communication clear and empathetic Leo, Daily Horoscope Today, January 7, 2025: Romantic life could be turbulent Leo, Daily Horoscope Today ...